(CercleFinance.com) – Roche launches a next generation qPCR system to meet clinical needs in molecular diagnostics.
The LightCycler PRO system is designed to be the most advanced qPCR technology for clinical diagnosis and research.
The new system will advance personalized healthcare and support epidemic preparedness by providing agility and flexibility for translational research and diagnostics.
The LightCycler PRO system further complements Roche’s molecular PCR testing portfolio, which includes solutions for a variety of healthcare professionals – from those performing research to those testing patients for cancer, diseases infectious diseases and other public health problems.
“Roche has made significant contributions to the establishment and advancement of PCR technology to meet the needs of healthcare systems,” said Josh Lauer, head of molecular laboratories at Roche Diagnostics.
‘Health systems have faced significant resource constraints and rapidly changing dynamics post-pandemic. The LightCycler PRO addresses these dynamics by providing the flexibility to seamlessly switch between research and clinical applications.
Copyright © 2023 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends using the buttons below.
